Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
about
Insights into gastric neuroendocrine tumors burdenPathophysiology of Gastric NETs: Role of Gastrin and Menin.Cell cycle dependent expression of the CCK2 receptor by gastrointestinal myofibroblasts: putative role in determining cell migration.Comparison of the human gastric microbiota in hypochlorhydric states arising as a result of Helicobacter pylori-induced atrophic gastritis, autoimmune atrophic gastritis and proton pump inhibitor use.Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
P2860
Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Netazepide, a gastrin/cholecys ...... ne chronic atrophic gastritis.
@en
Netazepide, a gastrin/cholecys ...... ne chronic atrophic gastritis.
@nl
type
label
Netazepide, a gastrin/cholecys ...... ne chronic atrophic gastritis.
@en
Netazepide, a gastrin/cholecys ...... ne chronic atrophic gastritis.
@nl
prefLabel
Netazepide, a gastrin/cholecys ...... ne chronic atrophic gastritis.
@en
Netazepide, a gastrin/cholecys ...... ne chronic atrophic gastritis.
@nl
P2093
P2860
P50
P356
P1476
Netazepide, a gastrin/cholecys ...... ne chronic atrophic gastritis.
@en
P2093
Andrea Varro
Andrew R Moore
Fiona Campbell
Helge L Waldum
Liv Sagatun
Malcolm Boyce
P2860
P304
P356
10.1111/BCP.13146
P407
P577
2016-10-04T00:00:00Z